AVE 0.00% 0.2¢ avecho biotechnology limited

300 priceline stores stock poh, page-19

  1. 5,322 Posts.
    Well lets look at it another way.

    Priceline sits quite nicely alongside Myer - which is also in the "mastige" segment and yet Nobody here voiced concern when Myer was announced as a stockist.

    So I see no inconsistancy in the positioning strategy at all. What we all want is sales sales and more sales- this is the correct postioning for Elixia. Its pricing across the range is mid market, its marketing is targeting mid market and mid market is the volume segment that will generate the highest sales volume and $ returns for POH.

    POH did not just arrive at this strategy by chucking darts at the wall. They have spend many months working with industry consultants and customers to devise their selling proposition and strategies. So I am content to let the experts shape the future of our personal care rollout and believe we are in very strong hands.

    BTW If you want to really talk upmarket look no further than Le Metier with products with a RRP of $300 and more...now thats what I call top end LOL
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.